{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-003544","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2022-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.656292+00:00","generated_at":"2026-06-27T20:20:02.018349+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Cytek Biosciences appoints Dr. Vera Imper to board of directors","bullets":["Board expanded from six to seven members; Dr. Imper appointed as Class II director effective Dec 31, 2021.","Dr. Imper receives $40,000 annual retainer and initial equity award of $300,000 (28,598 option shares at $16.32).","Initial options vest monthly over three years; annual equity grant of $160,000 at 2022 annual meeting.","Dr. Imper determined independent under Nasdaq rules; standard indemnification agreement in place."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-003544","json":"https://secwatch.observer/filing/0001193125-22-003544.json","markdown":"https://secwatch.observer/filing/0001193125-22-003544.md","text":"https://secwatch.observer/filing/0001193125-22-003544.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522003544/0001193125-22-003544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522003544/d284047d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:20:02.018349+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b86b780cd","claim":"Dr. Vera Imper was appointed as Class II director at Cytek Biosciences, Inc..","evidence_excerpt":"the Board unanimously voted to (i) increase the number of authorized directors on the Board from six to seven and (ii) appoint Dr. Vera Imper to serve as a Class II director of the Company, effective December 31, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522003544/0001193125-22-003544-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}